Improving Cardiovascular Health for Women: The Essentials for Every OB/GYN Practice Dr. Gersh discusses how to assess cardiovascular risk for women patients within an OB/GYN practice and how to utilize key lab tests, beyond standard lipid panels, to gain a deeper insight...

National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation Approximately 1 in 2 patients with atrial fibrillation do not optimally reduce their risk of stroke or bleeding when treated with the most widely prescribed...

Blood Cholesterol Trends 2001–2011 in the United States: Analysis of 105 Million Patient Records Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study...

Cardiovascular health and the well-woman visit: providing more comprehensive care Despite advances in gender-specific medicine, women are still less likely to receive guideline-recommended diagnostic testing and therapies, including cardiovascular screening...

Heart Failure Prevention, Diagnosis, and Management The role of natriuretic peptides and other biomarkers in the prevention, diagnosis, and management of heart failure. Update from the American College of Cardiology/American Heart Association/Heart Failure Society of America (ACC/AHA/HFSA) recommendations for the use of biomarkers in heart failure...

A lost decade: no meaningful changes in low-density lipoprotein cholesterol in the United States, 2008-2017: insights from a national reference laboratory A retrospective analysis of 126 million LDL-C test results determined that the average LDL-C blood level remained relatively stable for both men and women, regardless of age group...

Diabetes Report: US Patients Improved Diabetes Control Over 5-Year Period Quest Diagnostics Health Trends^™ Diabetes Report is based on 14.3 million test results from 2001–2005 from the nation’s largest database of clinical lab results...

Surge in Newly Identified Diabetes Among Medicaid Patients in 2014 Within Medicaid Expansion States Under the Affordable Care Act Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics, examines the impact of US Medicaid expansion on the number of Medicaid patients with newly identified diabetes...

Closing the Gap on Health Inequality Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics, reports that people in states that expanded Medicaid under the Affordable Care Act (ACA) are far more likely to be newly diagnosed with diabetes than those in states that elected not to expand the program. Based on a study published in Diabetes Care...

Insulin Resistance and Diabetes A discussion about insulin resistance and its relationship to prediabetes, type 2 DM, and other medical conditions ranging from cardiovascular to gynecologic. Also discussed are risk factors for insulin resistance, methods for diagnosis, and how lifestyle changes can treat insulin resistance and subsequently reduce the risk for developing diabetes...